Russell O, Lester S, Black RJ, Lassere M, Barrett C, March L, Lynch T, Buchbinder R, Hill CL. Area-level socioeconomic status impacts healthcare visit frequency by Australian inflammatory arthritis patients: results from the Australian Rheumatology Association Database. Arthritis Care Res. 2024; Accepted Author Manuscript.

Bryant MJ, Black RJ, Lester S, Chand V, Barrett C, Buchbinder R, Lassere M, March L, Hill CL. Australian adaptation and external validation of Commissioning for Quality in Rheumatoid Arthritis-RA-Patient Reported Experience Measure (CQRA-RA-PREM). Rheumatology Advances in Practice. 2024 Aug 17:rkae099.

Xue M, Lin H, Lynch T, Bereza-Malcolm L, Sinnathurai P, Thomas R, Keen H, Hill C, Lester S, Wechalekar M, March L. Exploring the association between circulating endothelial protein C receptor and disease activity of rheumatoid arthritis in a pilot study. Rheumatology Advances in Practice. 2024 Aug 6:rkae096.

Pisaniello HL, Lester SE, Russell O, Black R, Tieu J, Richards B, Barrett C, Lassere M, March L, Buchbinder R, Hill C. The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). Annals of the Rheumatic Diseases. 2024 May 29.

Mittinty MM, Mittinty MN, Buchbinder R, Lassere M, Chand V, Whittle S, March L, Hill C. Interpersonal process of dyadic coping in rheumatoid arthritis: a perspective from the Australian Rheumatology Association Database (ARAD). The Journal of Rheumatology. 2024 May 1.

Pisaniello H, Lester S, Russell O, Black R, Tieu J, Richards B, Barrett C, Lassere M, March L, Buchbinder R, Whittle S, Hill C. Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD). RMD Open​. 2023 Jul;9(3):e002962.

​McMaster C, Liew DFL, Lester S, Rischin A, Black RJ, Chand V, Fletcher A, Lassere MN, March L, Robinson PC, Buchbinder R, Hill CL. COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort. Rheumatology (Oxford). 2023 Apr 3;62(4):1460-1466.

​Lyon A, Quinlivan A, Lester S, Barrett C, Whittle SL, Rowett D, Black R, Sinnathurai P, March L, Buchbinder R, Hill CL. Vaccination Rates, Perceptions, and Information Sources Used by People With Inflammatory Arthritis. ACR Open Rheumatol. 2023 Feb;5(2):84-92.

​Black R, Lester S, Tieu J, Sinnathurai R, Barrett C, Buchbinder R, Lassere M, March L, Proudman S, Hill C. Mortality Estimates and Excess Mortality in Rheumatoid Arthritis. Rheumatology (Oxford). 2023.

Willers C, Lynch T, Chand V, Islam M, Lassere M, March L. A versatile, secure, and sustainable all-in-one biobank-registry data solution: The A3BC REDCap model. Biopreservation and biobanking. 2022 Jun 1;20(3):244-59.

​Quinlivan A, Lester S, Barrett C, Whittle S, Rowett D, Black R, Chand V, Marine F, March L, Sinnathurai P, Buchbinder R, Hill C. Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars. Rheumatology Advances in Practice. 2022;6(3).

​Fletcher A, Lassere M, March L, Hill C, Barrett C, Carroll G and Buchbinder R. Patterns of biologic and targeted-synthetic disease-modifying antirheumatic drug use in rheumatoid arthritis in Australia. Rheumatol. 2022.

​Rischin A, Liew D, Black R, Fletcher A, Buchbinder R, Lassere M, March L, Robinson P and Hill C. Healthcare access and attitudes towards telehealth during the early phase of the COVID-19 pandemic among an Australian cohort with inflammatory arthritis. Internal Medicine Journal. 2021;51:788-792.

​Venter G, Tieu J, Black R, Lester S, Leonardo N, Whittle SL, Hoon E, Barrett C, Rowett D, Buchbinder R and Hill CL. Perspectives of Glucocorticoid Use in Patients with Rheumatoid Arthritis. ACR Open Rheumatol. 2021;3:231-238.

​Fletcher AS, Lassere M, March L, Hill C, Carroll G, Barrett C and Buchbinder R. Use of Oral Complementary Medicine in Inflammatory Arthritis: Data from the Australian Rheumatology Association Database (ARAD). Int J Rheum. 2020;2020:9.

​Leonardo N, Lester S, Graham M, Barrett C, Whittle S, Rowett D, Buchbinder R and Hill C. Selection and perception of methotrexate treatment information in people with Rheumatoid Arthritis. Int J Rheum Dis. 2020;23:805-812.

​Black RJ, Richards B, Lester S, Buchbinder R, Barrett C, Lassere M, March L and Hill CL. Factors associated with commencing and ceasing opioid therapy in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2019;49(3):351-7.

​Sinnathurai P, Bartlett SJ, Halls S, Hewlett S, Orbai AM, Buchbinder R, Henderson L, Hill CL, Lassere M and March L. Investigating Dimensions of Stiffness in Rheumatoid and Psoriatic Arthritis: The Australian Rheumatology Association Database and OMERACT Collaboration. J Rheumatol. 2019;46(11):1462-1469.

​Staples MP, March L, Hill C, Lassere M and Buchbinder R. Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: an update from the Australian Rheumatology Association Database (ARAD) prospective cohort study. BMC Rheumatol. 2019;3:1.

​Lee JL, Sinnathura P, Buchbinder R, Hill C, Lassere M and March L. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study. Arthritis Res Ther. 2018;20.

Sinnathurai P, Capon A, Buchbinder R, Chand V, Henderson L, Lassere M, March L. Cardiovascular risk management in rheumatoid and psoriatic arthritis: online survey results from a national cohort study. BMC Rheumatol. 2018; 2: 25.

​Sinnathurai P, Buchbinder R, Hill C, Lassere M and March L. Comorbidity in psoriatic arthritis and rheumatoid arthritis. Intern Med J. 2018;48:1360-1368.

​Black RJ, Lester S, Buchbinder R, Barrett C, Lassere M, March L, Whittle S and Hill CL. Factors associated with oral glucocorticoid use in patients with rheumatoid arthritis: a drug use study from a prospective national biologics registry. Arthritis Res Ther. 2017;19:253.

​Buchbinder R, van Doornum S, Staples M, Lassere M, March L. Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort study. BMC Musculoskeletal Disorders. 2015;16:309.

Segan J, Staples M, March L, Lassere M, Chakravarty E, Buchbinder R.  Risk factors for herpes zoster in rheumatoid arthritis patients: the role of tumour necrosis factor-α inhibitors. Intern Med J. 2015;45(3):310-8.

​Kydd A, Chen J, Makovey J, Chand V, Henderson L, Buchbinder R, Lassere M, March L. Smoking did not modify the effects of anti-TNF treatment on health-related quality of life among Australian ankylosing spondylitis patients. Rheumatology. 2015;54(2):310-7. 

​Chen J, Makovey J, Lassere M, Buchbinder R, March L. Comparative effectiveness of anti-tumor necrosis factor drugs on health-related quality of life among patients with inflammatory arthritis.Arthritis Care Res. 2014;66(3): 464-472.

​Williams M, Buchbinder R, March L, Lassere M. The Australian Rheumatology Association Database (ARAD).Seminars in Arthritis and Rheumatism. 2011;40(4):e2-e3.

​Staples M, March L, Lassere M, Reid C, Buchbinder R. Health-related quality of life and continuation rate on first-line anti-tumour necrosis factor therapy among rheumatoid arthritis patients from the Australian Rheumatology Association Database (ARAD).Rheumatology. 2011;50(1):166-75.

​Briggs A, March L, van den Haak R, Hay N, Henderson L, Murphy B, Wengier L, Lassere M, Bendrups A, Buchbinder R. Stakeholder Satisfaction with the Australian Rheumatology Association Database (ARAD). Patient. 2009;2(1):61-68.

​Briggs A, March L, Lassere M, Reid C, Henderson L, Murphy B, Van den Haak R, Rischin A, Staples M, Buchbinder R. Baseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy: data from the Australian Rheumatology Association Database (ARAD). Int J Rheumatol. 2009;861481.

​Oldroyd J. Schachna L, Buchbinder R, Staples M, Murphy B, Bond M, Briggs A, Lassere M, March L. Ankylosing spondylitis patients commencing biologic therapy have high baseline levels of comorbidity: A report from the Australian Rheumatology Association Database. Int J Rheumatol. 2009:268569.

​Buchbinder R, March L, Lassere M, Briggs AM, Portek I, Reid C, Meehan A, Henderson L, Wengier L, van den Haak R. Effect of treatment with biological agents for arthritis in Australia: the Australian Rheumatology Association Database. Int Med J. 2007;37(9):591-600.

​

Posters & Oral Presentations (ARAD & A3BC)

Hee J, Nel H, Abraham Y, Chakradeo K, Roch M, Lynch T, March L, Wechalekar M, Keen H, Thomas R. Depletion of Citrullinated Vimentin-reactive Follicular Helper T Cells with Treatment-induced Remission of Recent-onset Rheumatoid Arthritis When Compared to Non-remission at 6 Months [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). ACR Convergence 2024.

Howard F, Lynch T, Munro J, Singh-Grewal D, Colagiuri S, Allen V, Hazel R, Chand V, Boros C, March L. Establishing the Australian Juvenile Arthritis Registry (AJAR) for children with JIA and other childhood rheumatic diseases (CRDs). Int J Rheum Dis. 2024;27(S2). Special Issue: 2024 Joint ARA and NZRA Annual Scientific Meeting, 18–21 May 2024, Te Pae, Christchurch, New Zealand.

Pietsch D, Roch M, Chakradeo K, Sweeney A, Lynch T, March L, Chand V, Kubler P, Thomas R. Is increased erythrocyte mean corpuscular volume and development of macrocytosis a marker of efficacy of methotrexate in rheumatoid arthritis? A report from the A3BC national registry & biobank. Int J Rheum Dis. 2024;27(S2). Special Issue: 2024 Joint ARA and NZRA Annual Scientific Meeting, 18–21 May 2024, Te Pae, Christchurch, New Zealand.

Xue M, Lin H, Lynch T, Chand V, Sinnathurai P, Thomas R, Keen H, Hill C, Lester S, Wechalekar M, March L. The correlations of circulating CD3-CD4+ cells with disease activity in patients with rheumatoid arthritis. Int J Rheum Dis. 2024;27(S2). Special Issue: 2024 Joint ARA and NZRA Annual Scientific Meeting, 18–21 May 2024, Te Pae, Christchurch, New Zealand.

Yi J, Lassere M, Portek I, Hill C, Wechalekar M, Proudman S, Whittle S, Thomas R, Gray J, Keen H, Liew D, Youssef P, Buchbinder R, Sinnathurai P, Laurent R, Deveza L, Hamid M, Liu X, Hong L, Sturgess A, Ng B, Lester S, Goldbatt F, Lynch T, Purni T, Chand V, Cross M, Shrestha R, Xue M, Lin H, Tuli J, Ruediger C, Cayzer A, Xing J, Griggs K, Altmann C, Briggs L, Roch M, Yang V, Lim A, March L. MRFF PROSPECT trial: A multi-centre, open-label, parallel-group randomised controlled trial of predicting disease-modifying anti-rheumatic drug dose tapering response in rheumatoid and psoriatic arthritis with economic evaluation: A preliminary report from NHMRC A3BC Centre of Research Excellence trial consortium. Int J Rheum Dis. 2024;27(S2). Special Issue: 2024 Joint ARA and NZRA Annual Scientific Meeting, 18–21 May 2024, Te Pae, Christchurch, New Zealand.

Witts M, Buchbinder R, Lester S, Chand V, Barrett C, Black R, Lassere M, March L, Kubler P, Hill C, Robinson P. Patient perspectives of DMARD monitoring in Australians with inflammatory arthritis. Int J Rheum Dis. 2024;27(S2). Special Issue: 2024 Joint ARA and NZRA Annual Scientific Meeting, 18–21 May 2024, Te Pae, Christchurch, New Zealand.

Bryant M, Black R, Lester S, Chand V, Barrett C, Buchbinder R, Lassere M, March L, Hill C. Adaptation and external validation of Commissioning for Quality in Rheumatoid Arthritis-PREM (CQRA-PREM). Int J Rheum Dis. 2024;27(S2). Special Issue: 2024 Joint ARA and NZRA Annual Scientific Meeting, 18–21 May 2024, Te Pae, Christchurch, New Zealand.

Lin H. The profiles of Th cell phenotypes and their correlations with disease activity in patients with rheumatoid arthritis. Int J Rheum Dis. 2024;27(S2). Special Issue: 2024 Joint ARA and NZRA Annual Scientific Meeting, 18–21 May 2024, Te Pae, Christchurch, New Zealand.

Tuli JF, Ruediger C, Lester S, Lynch T, Yi J, Briggs L, Cayzer A, Griggs K, Xing J, McWilliams L, Whittle S, Wechalekar M, Proudman S, March L, Hill C. Progress and Prospects: Recruitment Update for the Australian Arthritis and Autoimmune Biobank Collaborative (A3BC) Rheumatic Diseases Registry at the SA Hub. Australian Rheumatology Association (SA/NT) Annual Scientific Meeting, Adelaide 2023

​Lynch T, Thomas R, Keen H, Hill C, Lester S, Proudman S, Wechalekar M, Lassere M, Buchbinder R, Munro J, Singh-Grewal D, Perera C, Tymms K, Liew D, Sinnathurai P, Xue M, McInnes L, Lin H, Cross M, Chand V, Yi J, Howard F, Purni T, Grivei A, Herd K, Roch M, Ruediger C, Tuli J, Griggs K, Xing J, Briggs L, Cayzer A, Altmann C, March L. The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC) biobank & registry for rheumatic diseases: history, challenges and future directions. Australasian Biospecimen Network Association Conference 2023, Gold Coast.

Xue M, Lin H, Lynch T, Bereza-Malcolm L, Sinnathurai P, Thomas R, Keen H, Hill C, Lester S, Wechalekar M, March L. Increased endothelial protein C receptor correlates with disease activity and inflammatory cytokines in rheumatoid and psoriatic arthritis patients. Australian Rheumatology Association Annual Scientific Meeting, Hobart 2023.

Pisaniello HL, Lester S, Russell O, Black R, Tieu J, Richards B, Barrett C, Lassere M, March L, Buchbinder R, Hill C, Whittle S. Poorer pain-related health status in patients with rheumatoid arthritis correlates with an increase in hospitalizations and mortality: A prospective cohort analysis using the Australian Rheumatology Association Database. Australian Rheumatology Association Annual Scientific Meeting, Hobart 2023.

Pisaniello HL, Lester S, Russell O, Black R, Tieu J, Richards B, Barrett C, Lassere M, March L, Buchbinder R, Whittle S, Hill C. Trajectories of self-reported pain-related health outcomes and the association with sociodemographic factors and medication use in rheumatoid arthritis: A prospective cohort analysis using the Australian Rheumatology Association Database. Australian Rheumatology Association Annual Scientific Meeting, Hobart 2023.

Lynch T, Thomas R, Keen H, Hill C, Lester S, Wechalekar M, Lassere M, Buchbinder R, Munro J, Singh-Grewal D, Sinnathurai P, Xue M, Lightowler D, McInnes L, Bereza-Malcolm L, Lin H, Cross M, Chand V, Yi J, Grivei A, Herd K, Roch M, Tuli J, Briggs L, Weedon H, March L. Update on national recruitment for the Australian Arthritis and Autoimmune Biobank Collaborative [A3BC] biobank & registry for rheumatic diseases. Australian Rheumatology Association Annual Scientific Meeting, Hobart 2023.

Russell O, Lester S, Black R, Lassere M, Barrett C, March L, Lynch T, Buchbinder R, Hill C. The impact of area-level socioeconomic status (SES) on visits to general practitioners (GPs) and specialist physicians by inflammatory arthritis (IA) patients: an Australian Rheumatology Association Database (ARAD), Medicare (MBS) and Pharmaceutical Benefits Schedule (PBS) claims data linkage analysis. TQEH Research Expo 2023.

​Lynch T, Sinnathurai P, Buchbinder R, Hill C, Russell O, Lester S, Black R, Barrett C, Carroll G, Lassere M, March L. Predictors of discordant prescription medication self-report in the Australian Rheumatology Association Database (ARAD) cohort. Australian Rheumatology Association Annual Scientific Meeting 2022.

​Russell O, Lester S, Black R, Lassere M, Barrett C, March L, Lynch T, Buchbinder R, Hill C. Effect of socioeconomic status (SES) on opioid and glucocorticoid use in Australian rheumatoid arthritis (RA) patients: a medicine dispensing analysis using data from the Australian Rheumatology Association Database (ARAD). Australian Rheumatology Association Annual Scientific Meeting 2022.

Russell O, Lester S, Black R, Lassere M, Barrett C, March L, Lynch T, Buchbinder R, Hill C. The effect of area-level socioeconomic status (SES) on functional status in Australian rheumatoid arthritis (RA) patients: Data from the Australian Rheumatology Association Database (ARAD). Australian Rheumatology Association Annual Scientific Meeting 2022.

Willers C, Lynch T, Chand V, Islam M, Lassere M, Keen H, Kenna T, Lester S, Thomas R, Sinnathurai P, Wechalekar M, Fletcher A, Lightowler D, Mohd S, Ramnoruth N, Ruediger C, Weedon H, March L. A Combined Patient Registry and Biobank Laboratory Information System for Prospective Multisite Chronic Rheumatic Disease Research Using REDCap. ACR Convergence 2021.

Willers C, Lynch T, Chand V, Lassere M, Munro J, Xue M, Hill C, Wechalekar M, Thomas R, Kenna T, Keen H, Lester S, Islam M, March L. A “Free”, User-Configurable, Trusted and Scalable Patient Registry and Biobank LIMS Solution. ISBER Virtual Annual Meeting 2021.

​Fletcher A, March L, Lassere M, Hill C, Barrett C, Carroll G, Sinnathurai P, Buchbinder R. Australian Psoriatic Arthritis (PsA) Biologic Disease-modifying Antirheumatic Drug (bDMARD) Treatment Pathways Using Sankey Diagrams and Predictive Analysis: A Combined Australian Rheumatology Association Database (ARAD) and Pharmaceutical Benefits Scheme (PBS) Analysis. ACR Convergence 2021; 2021; San Francisco, USA.

Fletcher A, March L, Lassere M, Hill C, Barrett C, Carroll G and Buchbinder R. Australian psoriatic arthritis (PsA) biologic disease-modifying antirheumatic drug (bDMARD) treatment pathways: A combined Australian Rheumatology Association Database (ARAD) and Pharmaceutical Benefits Scheme (PBS) analysis. Cabrini Reseach Forum 2021; 2021; Melbourne.

​Fletcher A, March L, Lassere M, Hill C, Barrett C, Carroll G and Buchbinder R. Australian psoriatic arthritis (PsA) biologic disease-modifying antirheumatic drug (bDMARD) treatment pathways: A combined Australian Rheumatology Association Database (ARAD) and Pharmaceutical Benefits Scheme (PBS) analysis. Australian Rheumatology Association Annual Scientific Meeting; 2021; Sydney.

Bereza-Malcolm L, Xue M, Lynch T, Lin H, Lassere M, Jackson C, March L. Investigating the gut microbiome of patients with rheumatoid arthritis. Supplement: 2021 Australian Rheumatology Association 61st Annual Scientific Meeting, 21–23 May 2021, Hybrid Meeting with Satellite Hubs. International Convention Centre, Sydney and Adelaide, Brisbane, Hobart, Melbourne, Perth, Australia and Auckland, New Zealand. Aust Rheum Assoc. 2021;51(S2):5-52.

Rischin A, Liew D, Black R, Fletcher A, Buchbinder R, Lassere M, March L, Robinson P and Hill C. Healthcare access and attitudes towards telehealth during the early phase of the COVID-19 pandemic among an Australian cohort with inflammatory arthritis. Australian Rheumatology Association Annual Scientific Meeting; 2021; Sydney.

Black R, Lester S, Tieu J, Sinnathurai P, Barrett C, Buchbinder R, Lassere M, March L, Proudman S and Hill C. Mortality Associated with Rheumatoid Arthritis in Australian Rheumatology Association Database Participants. Australian Rheumatology Association Annual Scientific Meeting; 2021; Sydney.

Mittinty M, Mittinty N, Buchbinder R, Lassere M, Chand V, March L and Hill C. A perspective on dyadic coping from the Australian Rheumatology Association Database (ARAD). Australian Rheumatology Association Annual Scientific Meeting; 2021; Sydney.

Quinlivan A, Lester S, Barrett C, Whittle S, Rowett D, Black R, Chand V, Marine F, March L, Sinnathurai P, Buchbinder R and Hill C. Attitudes of Australians with inflammatory arthritis to biologic therapy and biosimilars. Australian Rheumatology Association Annual Scientific Meeting; 2021; Sydney.

Lyon A, Quinlivan A, Lester S, Barrett C, Whittle S, Marine F, Rowett D, Black R, Sinnathurai P, March L, Buchbinder R and Hill C. Vaccination rates, perceptions and information sources utilised by Australian patients with inflammatory arthritis. Australian Rheumatology Association Annual Scientific Meeting; 2021; Sydney.

Lynch T, Sinnathurai P, Fletcher A, Chand V, Buchbinder R, Hill C, Barrett C, Carroll G, Lassere M, March L. Assessing self-reported prescription medication validity in the Australian Rheumatology Association Database (ARAD) using Pharmaceutical Benefits Scheme (PBS) claims data. ARA-NSW ASM 2021

Russell O, Lester S, Black R, Lassere M, Barrett C, March L, Lynch T, Buchbinder R, Hill C. Effect of socioeconomic status (SES) on opioid and glucocorticoid use in Australian rheumatoid arthritis (RA) patients: a medicine dispensing analysis using data from the Australian Rheumatology Association Database (ARAD). Australian Rheumatology Association ARA SA/NT Annual Scientific Meeting 2021.

Dey A, Cross M, Lynch T, El-Haddad C, March L. Patient perspectives on biobanking and data-linkage for rheumatic disease research. American College of Rheumatology Convergence 2020; Virtual

​Venter G, Tieu J, Black R, Lester S, Leonardo N, Whittle S, Hoon E, Barrett C, Rowett D, Buchbinder R, Hill C. Perspectives of glucocorticoid use in a cohort of patients with rheumatoid arthritis. Australian Rheumatology Association Annual Scientific Meeting; 2020.

Dey A, Cross M, Lynch T, El-Haddad C, March L. Patient perspectives on biobanking and data-linkage for rheumatic diseases. In: 42nd Annual NSW Branch Meeting of the ARA; 2020 Dec 4; Sydney, Australia.

Bereza-Malcolm L, Xue M, Lynch T, Lassere M, Jackson C, March L. Investigating the gut microbiome of patients with rheumatoid arthritis. In: 42nd Annual NSW Branch Meeting of the ARA; 2020 Dec 5; Sydney, Australia.

​Fletcher A, March L, Lassere M, Hill C, Barrett C, Carroll G and Buchbinder R. Australian Rheumatoid Arthritis (RA) Biologic Treatment Pathways: An Australian Rheumatology Association Database (ARAD) Analysis. ACR/ARP Annual Meeting; 2019; Atlanta, USA.

​Fletcher A, March L, Lassere M, Hill C, Barrett C, Carroll G and Buchbinder R. Australian Rheumatoid Arthritis (RA) Biologic Treatment Pathways: An Australian Rheumatology Association Database (ARAD) Analysis. Australasian Epidemiological Association 2019 Annual Scientific Meeting; Brisbane.

​Fletcher A, Lassere M, March L, Buchbinder R, Lester S, Barrett C, Carroll G, Black R, Richards B and Hill C. Socioeconomic Differences in Opioid Use by People with Inflammatory Arthritis: data from the Australian Rheumatology Association Database (ARAD). Australasian Epidemiological Association 2019 Annual Scientific Meeting; Brisbane.

Lassere M, Fletcher AS, Black R, Barrett C, Carroll G, Lester S, Richards B, March L, Buchbinder R and Hill C. Socioeconomic Differences in Opioid Use by People with Inflammatory Arthritis: data from the Australian Rheumatology Association Database (ARAD). NSW ARA; 2019; Sydney.

Fletcher AS, Lassere M, March L, Buchbinder R, Lester S, Barrett C, Carroll G, Black R, Richards B and Hill C. Socioeconomic Differences in Opioid Use by People with Inflammatory Arthritis: data from the Australian Rheumatology Association Database (ARAD). Cabrini Research Week; 2019; Melbourne.

​Fletcher A, Lassere M, March L, Buchbinder R, Lester S, Barrett C, Carroll G, Black R, Richards B and Hill C. Socioeconomic Differences in Opioid Use by People with Inflammatory Arthritis: data from the Australian Rheumatology Association Database (ARAD). APLAR-ARA 2019; Brisbane

Bereza-Malcolm L. Understanding the connections between the microbiome, protease-activated receptor (PAR) activity and health outcomes in patients with rheumatoid arthritis. ARA-NSW 2019; Terrigal.

March L, Munro J, Hill C, Lester S, Jackson C, Xue M, Wechelakar M, Kenna T, Benham H, Keen H, Willers C, Perera C, Lassere M, Buchbinder R, Barrett C, Carroll G, Singh-Grewal D, Chaitow J, Hassett G, Lim I, Richards B, Thomas R, Brown M, Walter W, Chessman D, Oakley S, Sinnathurai P, Youssef P, Coiera E, Chatfield S, Cobb J, Gowdie P, Inouye M, Boros C, Ninan J, Pontifex E, Proudman S, Rischmueller M, Adib N, Kubler P, Ng J, Murray K, Walsh P, Raj AD, Hannan R, Kelly A, Khoo K, Tsai T, Tymms K, Black R, Cross M, Lynch T, Bereza-Malcolm L, Chand V, Fletcher A, Marine F. The Australian Arthritis & Autoimmune Biobank Collaborative (A3BC) & The Australian Rheumatology Association Database (ARAD). 21st Asia Pacific League of Associations for Rheumatology Congress (APLAR) in conjunction with the Australian Rheumatology Association, 2019, Brisbane.

​Fletcher A, Staples M, Hill C, Lassere M, March L, Carroll G, Barrett C, Chand V and Buchbinder R. Use of Oral Complementary Medicine in Inflammatory Arthritis: Data from the Australian Rheumatology Association Database (ARAD). ACR/ARHP Annual Meeting; 2018; Chicago, USA.

​Fletcher A, Lassere M, Black R, Barrett C, Carroll G, Lester S, Richards B, March L, Buchbinder R and Hill C. Socioeconomic Differences in Opioid Use by People with Inflammatory Arthritis. ACR/ARHP Annual Meeting; 2018; Chicago, USA.

​Fletcher A, Staples M, Hill C, Lassere M, March L, Henderson L, Carroll G, Barrett C, Chand V, McPhee J and Buchbinder R. Use of oral complementary medicine in inflammatory arthritis: data from the Australian Rheumatology Association Database (ARAD). Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2018;48 (Suppl 4):11.

​Fletcher A, Henderson L, Staples M, Chand V, Buchbinder R, Hill C, Lassere M, Carroll G, Barrett C and March L. Real-world experience with apremilast in an Australian cohort of people with psoriatic arthritis: prospective follow-up of participants in the Australian Rheumatology Association Database (ARAD). Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2018;48 (Suppl 4):13.

​Leonardo N, Lester S, M. G, Whittle S, Rowett D, Buchbinder R and Hill C. Attitudes of rheumatoid arthritis patients to methotrexate. Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2018;48 (Suppl 4):12.

​March L, Willers C, Ellis J, Cobb J, Lester S, Buchbinder R, Wechalekar M, Munro J, Benham H, Jackson C, Xue M, Hill C, Kenna T, Keen H, Perera C, Hassett G, Singh-Grewal D, Richards B, Lassere M, Youssef P, Lim I, Walsh P, Thomas R, Brown M, Adib N, Barrett C, Ng J, Rischmueller M, Boros C, Proudman S, Chessman D, Sinnathurai P, Oakley S, Chaitow J, Dowdie P, Chafield S, Inouye M, Kubler P, Tymms K, Kelly A, Tsai T, Raj A, Khoo K, Hannan R, Ninan J, Pontifex E and Murray K. The Australian Arthritis and Autoimmune Biobank Collaborative (A3BC) protocol. Australian Rheumatology Association Annual Scientific Meeting, Melbourne. Intern Med J. 2018;48 (Suppl 4):24.

March, L. The Australian Rheumatology Association Database (ARAD) and the Australian Arthritis and Autoimmune Diseases Biobank Collaborative (A3BC). ARA-NSW 2018, Terrigal.

​Black R, Lester S, Buchbinder R, Barrett C, Lassere M, March L,Whittle S, Hill C. Factors association with oral glucocorticoid use in patients with rheumatoid arthritis enrolled in the Australian Rheumatology Association Database (ARAD). Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2017;47 (Suppl. 2):5–41.

​Richards B, Black R, Lester S, Buchbinder R, Lassere M, March L, Hill C. Factors association with commencing and ceasing opioid therapy in a population-based cohort of patients with rheumatoid arthritis (RA): Data from the Australian Rheumatology Association Database (ARAD). Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2017;47 (Suppl. 2):5–41.

​Sinnathurai P, Halls S, Hewlett S, Orbai A, Bartlett S, BuchbinderR, Henderson L, Hill C, Lassere M, March L. Exploring dimensions of stiffness in rheumatoid arthritis and psoriatic arthritis: The Australian Rheumatology Association Database (ARAD) OMERACT stiffness survey. Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2017;47 (Suppl. 2):5–41.

​Staples M, March L, Lassere M, Buchbinder R. Australian rheumatoid arthritis biologic treatment pathways: An Australian Rheumatology Association Database (ARAD) analysis. Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2017;47 (Suppl. 2):5–41.

​Staples M, Lassere M, March L, Hill C, Buchbinder R. Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: An update from the Australian Rheumatology Association Database (ARAD) prospective cohort study. Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2017;47 (Suppl. 2):5–41.

March L, Munro J, Ellis J. The Australian Arthritis and Autoimmune Diseases Biobank Collaborative (A3BC). ARA 2017, Auckland.

​Sinnathurai P, Capon A, Buchbinder R, Chand V, Henderson L, Lassere M, March L. The Australian Rheumatology Association Database (ARAD) heart health survey: Management of cardiovascular risk factors in rheumatoid and psoriatic arthritis. Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2016;46 (Suppl. 2):5–50.

​Richards B, Buchbinder R, Lassere M, March L. Prevalence of pain, its impact and management in a population-based cohort of patients with rheumatoid arthritis: Data from the Australian Rheumatology Association Database (ARAD). Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2015;45 (Suppl. 2):1–46.

​Sinnathurai P, Lassere M, Buchbinder R, March L. Baseline characteristics of patients with psoriatic arthritis (PsA) form the Australian Rheumatology Association Database (ARAD). Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2015;45 (Suppl. 2):1–46.

​March L, Chen J, Makovey J, Lassere M, Buchbinder R. Comparing effectiveness of anti-tumour necrosis factor (TNF) drugs on patient reported health-related quality of life among Australian Rheumatology Association Database (ARAD) patients with inflammatory arthritis (RA, PsA and AS).  Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2013;43 (Suppl. 2):9–33.

Segan J, Staples M, Chand V, March L, Lassere M, Buchbinder R. Do tomour necrosis factor inhibitors increase the risk of herpes zoster in people with rheumatoid arthritis? A cohort study.  Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2013;43 (Suppl. 2):1–6.

Kydd A, Chen J, Makovey J, Chand V, Buchbinder R, Lassere M, March L. Ankylosing Spondylitis (AS) patients in the Australian Rheumatology Association Database (ARAD) have poorer health-related quality of life if they are current smokers.  Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2012;42 (Suppl. 1):9–35.

​Kyprianou K, Buchbinder R, Chand V, Staples M, Lassere M, March L, Akikusa J. Use of biological disease modifying anti-rheumatic drugs in children with juvenile idiopathic arthritis – a review of the Australian Rheumatology Association Database. ​ Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2012;42 (Suppl. 1):9–35.

​Van Doornum S, Staples M, Lassere M, March L,Buchbinder R. Non-melanoma skin cancer risk is increased in Australian RA patients treated with TNF antagonist therapy.  Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2012;42 (Suppl. 1):1–6.

​Williams B, March L, Buchbinder R, Reid C, Staples M, Lassere M. Risk and predictors of hospitalisation in rheumatoid arthritis patients on biological therapies: Results from the Australian Rheumatology Association Database (ARAD).  Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2012;42 (Suppl. 1):9–35.

​Oldroyd J, Staples M, Buchbinder R, Lassere M, Reid C, Murphy B, Henderson L, van  den  Haak R, Hay N, Bond M, March L. Arava use in an Australian population-based cohort of patients with Inflammatory Arthritis: Data from the Australian Rheumatology Association Database (ARAD).  Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2009;39 (Suppl. 2):A35–A82.

​Staples M, Oldroyd J, Murphy B, van den Haak R, Henderson L, Hay N, Bond M, March L, Lassere M, Buchbidner R. Changes in health related quality of life for arthritis patients taking biological disease modifying anti-rheumatic drugs: Data from the Australian Rheumatology Association Database.  Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2009;39 (Suppl. 2):A35–A82.

​Briggs A, March L, Murphy B, Van den Haak R, Henderson L, Hay N,Oldroyd J, Wengier L, Lassere M, Buchbinder R. Evaluation of stakeholder satisfaction of the Australian Rheumatology Association Database (ARAD).  Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2008;38 (Suppl. 2):A1–A36.

​Schachna L, Oldroyd J, Buchbinder R, Staples M, Lassere M, Reid C, Briggs A, Zochling J, Murphy B, Henderson L, van denHaak R, Hay N, Bond M, March L. Comorbidities in an Australian population-based cohort of patients with ankylosing spondylitis commencing biological therapy: Data from the Australian Rheumatology Association Database (ARAD).  Australian Rheumatology Association Annual Scientific Meeting. Intern Med J. 2008;38 (Suppl. 2):A1–A36.

​Briggs A, March L, Lassere M, Wengier L, van den Haak R, Henderson L, Reid C, Buchbinder R. Evaluation of selection bias in the Australian Rheumatology Association Database (ARAD). Australian Rheumatology Association Annual Scientific Meeting. Int Med J. 2007;37 (Suppl. 2):A27–A62.

​Briggs A, Wengier L, van den Haak R, L Henderson, March L, Lassere M, Reid C, Buchbinder R. Agreement between patient and rheumatologist reports of medication side effects and history of malignancy. Australian Rheumatology Association Annual Scientific Meeting. Int Med J. 2007;37 (Suppl. 2):A27–A62.

Briggs A, March L, Lassere M, Reid C, Portek I, Wengier L, van den Haak R, Henderson L, Buchbinder R. Baseline comorbidity in Australian patients receiving biological therapy for rheumatoid arthritis. Australian Rheumatology Association Annual Scientific Meeting. Int Med J. 2007;37 (Suppl. 2):A27–A62.

​Briggs A, Staples M, March L, Lassere M, Reid C, Henderson L, Wengier L, van den Haak R, Buchbinder R. The rate of infection after six months of bDMARD therapy is greater than at initiation of therapy. Australian Rheumatology Association Annual Scientific Meeting. Int Med J. 2007;37 (Suppl. 2):A27–A62.